Young Wendy B. 4

What Happened Wendy B. Young, a director of Rapport Therapeutics, was granted a derivative award on 2026-06-10 covering 15,200 shares. The grant is reported at $0.00 (no cash paid on grant) and is recorded as an award/grant (transaction code A). This is an equity award/option grant—not a sale or purchase of common stock—and does not represent immediate proceeds or a market sale.

Key Details

• Transaction date: 2026-06-10; Form 4 filed the same day (timely).
• Reported amount: 15,200 shares (derivative security) at $0.00 acquisition price.
• Transaction code: A (award/grant of a derivative security).
• Vesting note: The shares underlying this option vest upon the earlier of (i) June 10, 2027 or (ii) the date of the next Annual Meeting of Stockholders, subject to continued service (per footnote).
• Shares owned after the transaction: not specified in the filing.

Context This filing documents an option/award grant that vests in the future and does not indicate an immediate purchase or sale of stock. Such grants are commonly part of director compensation and do not, by themselves, signal near-term buying or selling activity.